Antiparkinson Agents (administration & dosage) < Antiparkinson Agents (adverse effects) < Antiparkinson Agents (antagonists & inhibitors)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 373.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000006 (1999)	F. Durif [France] ; M. Vidailhet ; B. Debilly ; Yves Agid [France]	Worsening of levodopa-induced dyskinesias by motor and mental tasks.
000007 (1999)	A. Churchyard [Royaume-Uni] ; C J Mathias ; A J Lees	Selegiline-induced postural hypotension in Parkinson's disease: a longitudinal study on the effects of drug withdrawal.
000047 (1999)	P. Hagell [Suède] ; H. Widner	Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale.
000053 (1999)	H H Fernandez [États-Unis] ; J H Friedman ; C. Jacques ; M. Rosenfeld	Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
000062 (1999)	S. Spieker [Allemagne] ; P A Löschmann ; T. Klockgether	The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations.
000070 (1999)	D. Caparros-Lefebvre ; A. Lannuzel ; F. Tiberghien ; M. Strobel	Protease inhibitors enhance levodopa effects in Parkinson's disease.
000097 (1999)	J. Fine ; A E Lang	Dose-induced penile erections in response to ropinirole therapy for Parkinson's disease.
000101 (1999)	R K Pearce [Royaume-Uni]	L-dopa and dyskinesias in normal monkeys.
000102 (1999)	M. Vidailhet [France] ; A M Bonnet ; R. Marconi ; F. Durif ; Yves Agid [France]	The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
000103 (1999)	O. Rascol [France]	L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
000105 (1999)	J M Brotchie [Royaume-Uni] ; S H Fox	Quantitative assessment of dyskinesias in subhuman primates.
000106 (1999)	C G Goetz [États-Unis]	Rating scales for dyskinesias in Parkinson's disease.
000108 (1999)	H. Widner [Suède] ; G L Defer	Dyskinesias assessment: from CAPIT to CAPSIT. Core Assessment Program for Intracerebral Transplantations. Core Assessment Program for Surgical Interventional Therapies.
000111 (1999)	J. Nutt [États-Unis]	A unified dyskinesias rating scale for L-dopa-induced dyskinesias?
000129 (1999)	H H Fernandez [États-Unis] ; J H Friedman	Punding on L-dopa.
000149 (1999)	Yves Agid [France] ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; Werner Poewe [Autriche] ; P. Pollak ; E. Tolosa	Levodopa in the treatment of Parkinson's disease: a consensus meeting.
000159 (1999)	J. Kimber [Royaume-Uni] ; L. Watson ; C J Mathias	Neuroendocrine responses to levodopa in multiple system atrophy (MSA).
000164 (1999)	G. Ebersbach [Autriche] ; M. Stöck ; J. Müller ; G. Wenning ; J. Wissel ; Werner Poewe [Autriche]	Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration.
000165 (1999)	E S Molho [États-Unis] ; S A Factor	Worsening of motor features of parkinsonism with olanzapine.
000168 (1999)	C. Dentresangle [France] ; L. Veyre ; D. Le Bars ; C. Pierre ; F. Lavenne ; P. Pollak ; J. Guerin ; J C Froment ; E. Brousolle	Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
000183 (2000)	L V Metman ; S. Konitsiotis ; T N Chase	Pathophysiology of motor response complications in Parkinson's disease: hypotheses on the why, where, and what.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (adverse effects)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024